Sinai Health System

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Crohn's disease2 trials
• Ovarian cancer2 trials
• Childhood cancers1 trial
• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial
• Ulcerative colitis1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Recruiting4 trials
• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Canadian Cancer Trials Group2 trials
• Mount Sinai Hospital, Canada2 trials
• University Health Network, Toronto2 trials
• University of Calgary1 trial

Running trials

• Recruiting

  CfDNA in Hereditary And High-risk Malignancies 2

  NCT06726642· University Health Network, Toronto· Source

  Contact: Raymond Kim, MD

• Recruiting

  PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

  NCT05928039· Phase 4· University of Calgary· Source

  Contact: Hillary Steinhart

• Recruiting

  Genome Analysis Across Populations in Inflammatory Bowel Disease

  NCT06042387· Mount Sinai Hospital, Canada· Source

  Contact: Joanne Stempak, MSc

• Active, not recruiting

  Cell-free DNA in Hereditary And High-Risk Malignancies 1

  NCT04261972· University Health Network, Toronto· Source

• Recruiting

  Non-operative Management for Locally Advanced Rectal Cancer

  NCT03179540· Mount Sinai Hospital, Canada· Source

  Contact: Erin Kennedy

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease2 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Ovarian cancer1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

  NCT02273375· Phase 3· Canadian Cancer Trials Group· Source

• Completed

  Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

  NCT00819208· Canadian Cancer Trials Group· Source